01 1THINQ Pharma-CRO PVT Ltd
01 1CETIRIZINE HYDROCHLORIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-06-01
Pay. Date : 2014-12-24
DMF Number : 28887
Submission : 2015-01-14
Status : Active
Type : II
20
Thinq Pharma-cro Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CETIRIZINE HYDROCHLORIDE USP, with a corresponding US DMF Number 28887.
Remarkably, this DMF maintains an Active status since its submission on January 14, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 01, 2015, and payment made on December 24, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
